Thomas Lee Jang MD MPH, FACS
Minimally Invasive Surgery, Surgical Oncology
Professor and Chief of Urologic Oncology at the Rutgers Cancer Institute; Program Director, Rutgers RWJ Medical School Urology Residency Training Program
Join to View Full Profile
165 Somerset StreetNew Brunswick, NJ 08901
Dr. Jang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Urologic Surgical Oncology, 2006 - 2009
McGaw Medical Center of Northwestern UniversityResidency, Urology, 2002 - 2006- McGaw Medical Center of Northwestern UniversityResidency, Surgery, 2000 - 2002
Northwestern University Graduate SchoolMPH, Epidemiology & Biostatistics, 2000 - 2001- Northwestern University The Feinberg School of MedicineClass of 2000
Certifications & Licensure
NJ State Medical License 2009 - 2027
NY State Medical License 2006 - 2027
ND State Medical License 2009 - 2026
IL State Medical License 2000 - 2008
American Board of Urology Urology
Awards, Honors, & Recognition
- Recognition as Testicular Cancer Expert Testicular Cancer Resource Center/Testicular Cancer Society
- Residents and Fellows Committee Teaching Award Nominee American Urological Association, 2021
- New Jersey Monthly Top Doctor in Urology/Urologic Oncology NJ Monthly, 2020
Clinical Trials
- Retroperitoneal Lymph Node Dissection in Treating Patients With Testicular Seminoma Start of enrollment: 2015 Aug 28
- Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy Start of enrollment: 2017 Apr 28
- Therapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate Cancer Start of enrollment: 2018 Mar 20
Publications & Presentations
PubMed
- Comparative outcomes of radical nephroureterectomy and kidney-sparing surgery in the treatment of high-grade upper tract urothelial carcinoma.Kyle Moore, Helen Gao, Benjamin Lichtbroun, Jennifer Delgado, Anirudh Kulkarni
Urologic Oncology. 2025-11-01 - 1 citationsBacillus Calmette-Guérin (BCG) in combination with PANVAC™ vs. BCG alone in adults with high-grade BCG-refractory non-muscle-invasive bladder cancer.Matthew Ho, Alon Lazarovich, Ragheed Saoud, Aaron Dahmen, Samuel Tremblay
Urologic Oncology. 2025-11-01 - Investigating the Usage of Abiraterone in African American Men with Metastatic Prostate Cancer.Christine Ibilibor, Marieke Jones, Jeffrey Tomaszewski, Serge Ginzburg, Andres Correa
Journal of Racial and Ethnic Health Disparities. 2025-06-24
Journal Articles
- Trends and Outcomes of Lymphadenectomy for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-Weighted Analysis of the National Cancer DatabaseParth K Modi, Tina M Mayer, Isaac Y Kim, Sammy E Elsamra, Thomas L Jang, Eric A Singer, Urologic Oncology
Press Mentions
Check Yourself: Why Being Proactive About Testicular Cancer MattersApril 1st, 2025- April Is Testicular Cancer Awareness MonthApril 26th, 2023
- Rutgers Cancer Institute of New Jersey Experts Available for Comment During Men’s Health MonthJune 7th, 2021
Professional Memberships
- Member
- Society of Urologic OncologyMember
- Member
Other Languages
- Taiwanese
External Links
- CINJ Urologic Oncology Programhttps://cinj.org/thomas-jang-md-mph-facs
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
